Dr Reddy's delayed Semaglutide supplies after certain batches failed quality specifications due to an API issue. The company ...

Dr. Reddy’s Laboratories Ltd. will delay the commercial production of its generic Ozempic drug after it found an unspecified ...

Hyderabad: Dr. Reddy's Laboratories has announced a temporary delay in the commercial supply of certain batches of its ...

DeepSeek API migration is mandatory before July 24, 2026 — after that, deepseek-chat and deepseek-reasoner return errors.

The company expects shipments to resume by November, and has halves FY27 supply estimate, while saying patient safety and ...

Dr Reddy's Laboratories stated that certain batches of semaglutide were found to be out of specification due to an issue associated with the active pharmaceutical ingredient (API) used in the product.

When launching a drug as big as semaglutide, even as a generic, the market expectations are immense, and any fumble on the ...

The danger in WebMCP isn't a malicious site. It's your own user comments, carrying instructions an agent can't tell from ...

VANCOUVER, BC / ACCESS Newswire / July 10, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") announces the successful completion of its ...

New capability expands Apex's connected review platform across Amazon, Meta business accounts, websites, documents, images, videos, and pre-published marketing content BOULDER, CO / ACCESS Newswire / ...

Three Indian pharmaceutical companies, Dr. Reddy's Laboratories, Torrent Pharmaceuticals and USV, have initiated voluntary ...

Dr Reddy's Laboratories said that commercial production of semaglutide has been delayed due to an active ingredient-related issue in certain batches ...